ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 269721 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 269721; 2) Community: the network communities that were significantly associated with the response to NSC 269721; 3) Molecule: the relationships between components within communities and NSC 269721; 4) MDR: the compounds that were significantly associated with the NSC 269721.

NSC Compound Enrichment Correlation
NSC 632573 Tris(1,3-diphenylpropane-1,3-dionata)gallium(III) 0.0430505868034758 0.43768395
NSC 640644 Null 0.0430505868034758 0.0026564055
NSC 672159 Null 0.0430505868034758 0.18700136
NSC 684908 Null 0.0430505868034758 0.40063075
NSC 704171 Null 0.0430505868034758 0.044601629
NSC 708048 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, ethyl ester, (2Z,1E)- 0.0430505868034758 0.12641638
NSC 129185 Melbex 0.0430505868034761 0.40993579
NSC 132277 Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) 0.0430505868034761 0.33006744
NSC 135073 WITHACNISTIN 0.0430505868034761 0.15666633
NSC 176323 Camptothecin Derivative 0.0430505868034761 0.55029745
Total:61  Current:53    [First] [Prev] [Next] [Last]